Sickle Cell Patient with Fever Clinical Pathway Patients with sickle cell disease (SCD) are at increased risk of severe bacterial infections, in large part due to reduced or absent splenic function. Repeated episodes of sickling and infarction lead to ‘autosplenectomy,’ often by age three years. Functionally asplenic patients
Diabetic Ketoacidosis Clinical Pathway Diabetic Ketoacidosis (DKA) is a potentially fatal metabolic complication of uncontrolled diabetes mellitus. DKA consists of the biochemical triad of hyperglycemia, ketonemia and metabolic acidosis, resulting from absolute or relative insulin deficiency in the presence of an
Pediatric Cardio-Oncology Acute Cardiotoxicity Primary and Secondary Prevention Strategies Clinical Pathway Cardio-oncology is an emerging field. Childhood cancer survivors receive numerous cancer treatments that are cardiotoxic. Among the nearly 500,000 long-term childhood cancer survivors in the United States, more than half were treated with cardiotoxic cancer therapy, which results
Ketogenic Diet and Modified Ketogenic Diet Clinical Pathway Ketogenic and modified ketogenic diets are high fat, low carbohydrate diets used as evidence-based treatment for intractable seizures. These pathways were developed to aid with initiation of these diets for established neurology patients at Connecticut Children’s. Initiation of
Service/Program
Pediatric Tracheostomy There are many reasons that a child may need a tracheostomy, a surgical procedure used to create an opening through the neck into the trachea (windpipe). For example, when a child’s airway is permanently blocked, cannot be cleared of secretions or must be supported by a Burn Clinical Pathway Connecticut Children’s cares for patients with mild to moderately burns. Burn injury can vary in severity from superficial to partial thickness to full thickness. Connecticut Children’s has not had a standardized approach to care for these children in the past. A standardized
Asthma (Emergency Department and Inpatient) Clinical Pathway In the United States, asthma affects 7 million children under 18 years. In 2010, 58.3% of children with asthma had at least one asthma attack in the previous twelve months. Nearly 20% of children diagnosed with asthma went to an ED for care in 2009. Asthma is the third¬ ranking
Ischemic Stroke Evaluation and Management Clinical Pathway Pathway Background Stroke is a neurological injury caused by the occlusion or rupture of cerebral blood vessels. Strokes can be ischemic, hemorrhagic, or both. Ischemic stroke is most frequently caused by arterial occlusion, but may be caused by venous occlusion of cerebral veins
Specialty
Dentistry If your child needs a dental specialist, you’ve come to the right place. The pediatric dentists and oral and maxillofacial surgeons who practice at Connecticut Children’s specialize in treating the full spectrum of dental needs for children of all ages. From impacted wisdom teeth Tonsillectomy and Adenoidectomy: Perioperative Care Clinical Pathway Tonsillectomy and adenoidectomy is a common procedure with greater than 500,000 performed annually in the United States. However, there is variability in peri-operative and post-operative care for these patients. This can lead to confusion and dissatisfaction for patients
Esophageal Button Battery Management Clinical Pathway In the US, approximately 3,500 children are treated annually in emergency departments for button battery ingestion. Button batteries that are lodged in the esophagus have the potential to cause catastrophic thermal injuries. Quick recognition and removal of the battery leads to
Suspected Nephrolithiasis Clinical Pathway Studies have demonstrated an increasing incidence of pediatric stone disease over the past 20 years. In addition, there has been a shift to outpatient care of patients with nephrolithiasis, particularly to the Emergency Department setting. Despite published national guidelines
Referrals Find resources for referring patients to Connecticut Children's, including access to EpicCare Link, directions to submit an online referral form, and contact information for our OneCall physician access line.
Hemangioma Management Clinical Pathway Infantile hemangiomas are common benign tumors that can cause significant complications such as permanent disfigurement, ulceration, bleeding, visual compromise, airway obstruction, and congestive heart failure. They affect up to 2-5% of all infants and up to 30% of premature